A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia
Status:
Withdrawn
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This is a phase-I, double-blind, randomized study with hLF1-11 to study the tolerability and
early efficacy of hLF1-11 compared to standard fluconazole therapy in hospitalized patients
with invasive Candida infection.